nerinetide   Click here for help

GtoPdb Ligand ID: 12332

Synonyms: NA-1 | Tat-NR2B9c
Comment: Nerinetide (NA-1) is a peptide that was designed to target the PDZ domain of the PSD-95 protein (gene symbol DLG4) [1] to prevent its interaction with N-methyl-D-aspartate receptors (NMDARs) and neuronal nitric oxide synthase (nNOS) and block assembly of the tri-peptide complex that is a therapeutic target for the treatment of acute ischemic stroke [2-3]. Structurally, nerinetide is a 20 amino acid linear peptide that comprises nine residues derived from the COOH-terminal of the NR2B NMDAR (GluN2B; GRIN2B; that directly interacts with PSD-95's PDZ2 domain) fused to 11 amino acid cell-membrane transduction domain of the HIV-1 Tat protein (Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg; to create a cell permeable peptide). The NMDAR/nNOS/PSD-95 complex mediates neurotoxic signaling, and disruption of this function provides a neuroprotective effect that ameliorates ischemic brain damage, without inducing the negative consequences that can arise through NMDAR blockade.
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)CC(=O)O)CO)CCC(=O)O)[C@H](CC)C)CO)CO)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N)CCCNC(=N)N)CCCCN)CCCCN)CCCNC(=N)N)CCCNC(=N)N)CCC(=O)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N
Isomeric SMILES CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N
InChI InChI=1S/C105H188N42O30/c1-7-55(6)80(98(175)140-69(34-36-77(154)155)92(169)143-72(50-148)95(172)142-71(48-78(156)157)94(171)146-79(54(4)5)99(176)177)147-97(174)74(52-150)145-96(173)73(51-149)144-93(170)70(46-53(2)3)141-90(167)62(22-10-13-39-108)133-85(162)63(24-15-41-124-101(113)114)135-87(164)65(26-17-43-126-103(117)118)136-88(165)66(27-18-44-127-104(119)120)138-91(168)68(33-35-75(110)152)139-89(166)67(28-19-45-128-105(121)122)137-86(163)64(25-16-42-125-102(115)116)134-84(161)61(21-9-12-38-107)132-83(160)60(20-8-11-37-106)131-82(159)59(23-14-40-123-100(111)112)130-76(153)49-129-81(158)58(109)47-56-29-31-57(151)32-30-56/h29-32,53-55,58-74,79-80,148-151H,7-28,33-52,106-109H2,1-6H3,(H2,110,152)(H,129,158)(H,130,153)(H,131,159)(H,132,160)(H,133,162)(H,134,161)(H,135,164)(H,136,165)(H,137,163)(H,138,168)(H,139,166)(H,140,175)(H,141,167)(H,142,172)(H,143,169)(H,144,170)(H,145,173)(H,146,171)(H,147,174)(H,154,155)(H,156,157)(H,176,177)(H4,111,112,123)(H4,113,114,124)(H4,115,116,125)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)/t55-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,79-,80-/m0/s1
InChI Key XWQVQFBTSBCKLI-FKXNDIMNSA-N
Classification Click here for help
Compound class Peptide or derivative
International Nonproprietary Names Click here for help
INN number INN
10857 nerinetide
Synonyms Click here for help
NA-1 | Tat-NR2B9c
Database Links Click here for help
CAS Registry No. 500992-11-0 (source: WHO INN record)
GtoPdb PubChem SID 479821123
PubChem CID 44568939
Search Google for chemical match using the InChIKey XWQVQFBTSBCKLI-FKXNDIMNSA-N
Search Google for chemicals with the same backbone XWQVQFBTSBCKLI
Search PubMed clinical trials nerinetide
Search PubMed titles nerinetide
Search PubMed titles/abstracts nerinetide
UniChem Compound Search for chemical match using the InChIKey XWQVQFBTSBCKLI-FKXNDIMNSA-N
UniChem Connectivity Search for chemical match using the InChIKey XWQVQFBTSBCKLI-FKXNDIMNSA-N